Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-028066
Filing Date
2024-12-03
Accepted
2024-12-03 16:09:46
Documents
1
Period of Report
2024-12-01

Document Format Files

Seq Description Document Type Size
1 form4-12032024_091242.html 4  
1 form4-12032024_091242.xml 4 7437
  Complete submission text file 0001415889-24-028066.txt   8966
Mailing Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Issuer) CIK: 0001382101 (see all company filings)

EIN.: 452441988 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O SUTRO BIOPHARMA, INC. 310 UTAH AVE., SUITE 150 SOUTH SAN FRANCISCO CA 94080
Business Address
Chung Jane (Reporting) CIK: 0001872398 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38662 | Film No.: 241522856